Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis

Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. Objective To evaluate MRI features associated with Grade III ASPS...

Full description

Saved in:
Bibliographic Details
Published inJournal of magnetic resonance imaging Vol. 61; no. 3; pp. 1482 - 1491
Main Authors Yuan, Junhui, Xie, Deshun, Fang, Shaobo, Meng, Fan, Shan, Dongqiu, Wang, Yuanyuan, Du, Xinhui, Xu, Chunmiao, Zhang, Renzhi, Chen, Xuejun
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.03.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1053-1807
1522-2586
1522-2586
DOI10.1002/jmri.29545

Cover

Abstract Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. Objective To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis. Study Type Retrospective analysis. Subjects Sixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients. Field Strength/Sequence A 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo). Assessment MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade. Statistical Tests The chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features. Results Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84). Data Conclusion MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis. Evidence Level 4 Technical Efficacy Stage 5
AbstractList Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.BACKGROUNDAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.OBJECTIVETo evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.Retrospective analysis.STUDY TYPERetrospective analysis.Sixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients.SUBJECTSSixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients.A 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo).FIELD STRENGTH/SEQUENCEA 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo).MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade.ASSESSMENTMRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade.The chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.STATISTICAL TESTSThe chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84).RESULTSTumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84).MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.DATA CONCLUSIONMRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.4 TECHNICAL EFFICACY: Stage 5.EVIDENCE LEVEL4 TECHNICAL EFFICACY: Stage 5.
BackgroundAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival.ObjectiveTo evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis.Study TypeRetrospective analysis.SubjectsSixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients.Field Strength/SequenceA 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo).AssessmentMRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade.Statistical TestsThe chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features.ResultsTumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84).Data ConclusionMRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis.Evidence Level4Technical EfficacyStage 5
Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis. Retrospective analysis. Sixty-seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow-up and survival analysis on 50 patients. A 3.0 T, T1WI-FSE, T2WI-FSE, DWI-EPI, DCE-MRI (gradient echo). MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time-intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high-grade. The chi-square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high-grade tumors. The Kaplan-Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features. Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high-grade ASPS. Tumor necrosis was an independent factors associated with local relapse-free survival (odds ratio [OR], 3.88). TIC type was associated with 5-year survival rate (OR, 2.80) and local relapse-free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5-year survival (OR, 4.00), local relapse-free survival (OR, 5.58), and local relapse-free survival (OR, 4.84). MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis. 4 TECHNICAL EFFICACY: Stage 5.
Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can lead to underestimation, affecting treatment, and patient survival. Objective To evaluate MRI features associated with Grade III ASPS and to determine the relationship between MRI features and patient prognosis. Study Type Retrospective analysis. Subjects Sixty‐seven patients with ASPS were included with 37 males and 30 females (M/F = 1.23) follow‐up and survival analysis on 50 patients. Field Strength/Sequence A 3.0 T, T1WI‐FSE, T2WI‐FSE, DWI‐EPI, DCE‐MRI (gradient echo). Assessment MRI features (margin, peritumoral oedema, peritumoral enhancement, necrosis, vascular flow void signal, heterogeneous signal intensity [SI] at T1WI and T2WI, ADCmean, time‐intensity curve [TIC] type, distant metastasis, and bone invasion) and histological grading were independently evaluated by three radiologists and two pathologists, with Grade III considered high‐grade. Statistical Tests The chi‐square or Fisher's exact test was used to assess the correlation between MRI features and histological grading. Multivariable binary logistic regression identified independent factors associated with high‐grade tumors. The Kaplan–Meier method and Cox proportional hazards model were used to calculate hazard ratios for MRI features. Results Tumor necrosis, heterogeneous SI at T2WI ≥50%, and ADCmean were associated with high‐grade ASPS. Tumor necrosis was an independent factors associated with local relapse‐free survival (odds ratio [OR], 3.88). TIC type was associated with 5‐year survival rate (OR, 2.80) and local relapse‐free survival (OR, 2.69). Heterogeneous SI at T2WI ≥50% was associated with 5‐year survival (OR, 4.00), local relapse‐free survival (OR, 5.58), and local relapse‐free survival (OR, 4.84). Data Conclusion MRI features including tumor necrosis, heterogeneity of SI at T2WI, ADCmean, and TIC type aid in assessing ASPS grading and prognosis. Evidence Level 4 Technical Efficacy Stage 5
Author Wang, Yuanyuan
Xie, Deshun
Chen, Xuejun
Meng, Fan
Shan, Dongqiu
Zhang, Renzhi
Xu, Chunmiao
Du, Xinhui
Fang, Shaobo
Yuan, Junhui
Author_xml – sequence: 1
  givenname: Junhui
  surname: Yuan
  fullname: Yuan, Junhui
  organization: The First Affiliated Hospital of Fujian Medical University
– sequence: 2
  givenname: Deshun
  surname: Xie
  fullname: Xie, Deshun
  organization: Heze Municipal Hospital
– sequence: 3
  givenname: Shaobo
  orcidid: 0000-0003-0645-5463
  surname: Fang
  fullname: Fang, Shaobo
  organization: Zhengzhou University People's Hospital & Henan Provincial People's Hospital, Academy of Medical Sciences, Zhengzhou University
– sequence: 4
  givenname: Fan
  surname: Meng
  fullname: Meng, Fan
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
– sequence: 5
  givenname: Dongqiu
  surname: Shan
  fullname: Shan, Dongqiu
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
– sequence: 6
  givenname: Yuanyuan
  surname: Wang
  fullname: Wang, Yuanyuan
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
– sequence: 7
  givenname: Xinhui
  surname: Du
  fullname: Du, Xinhui
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
– sequence: 8
  givenname: Chunmiao
  orcidid: 0000-0003-4064-5447
  surname: Xu
  fullname: Xu, Chunmiao
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
– sequence: 9
  givenname: Renzhi
  surname: Zhang
  fullname: Zhang, Renzhi
  email: zhangrenzhi7790@126.com
  organization: National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
– sequence: 10
  givenname: Xuejun
  orcidid: 0000-0001-6124-7312
  surname: Chen
  fullname: Chen, Xuejun
  email: chenxuejun1967@163.com
  organization: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39037329$$D View this record in MEDLINE/PubMed
BookMark eNp90U1P3DAQBmCroiqw7YUfUFnqBSEFxl9J3Bta8VVRgQoVR8tJJluvHBvspBX_nmyX9tBDT_bhmdHofffJTogBCTlgcMwA-Ml6SO6YayXVG7LHFOcFV3W5M_9BiYLVUO2S_ZzXAKC1VO_IrtAgKsH1HnGn_idGbxO9i_1I713OE9I7m9o42M90GVNCb0cXA409_frtip6jHaeEmT648Qe9dHmMPq5caz29SLZzYUVt6OjtPIRhpLcprkLMLr8nb3vrM354fRfk-_nZ_fKyuL65uFqeXhetYKUqqr6sARvUpZUla_quEtBIzqQQDXSyLkUnsWolgCo5qlJ1lrUNY7q3uq2UFAtyuN37mOLThHk0g8stem8DxikbAbXgTNcgZvrpH7qOUwrzdWa-RXIhNgkuyMdXNTUDduYxucGmZ_MnxBkcbUGbYs4J-7-Egdk0ZDYNmd8NzZht8S_n8fk_0nyZ097OvADenZEs
Cites_doi 10.1177/1758834017705588
10.1016/j.diii.2018.02.005
10.1002/jso.24183
10.1148/radiol.14131871
10.2174/1573405616999200729152135
10.5858/2006-130-1448-GOSTSR
10.1007/s00330-018-5845-9
10.1016/j.humpath.2016.06.008
10.1016/S1470-2045(17)30334-0
10.1002/jmri.25791
10.1056/NEJMoa2303383
10.1002/jmri.26659
10.21037/qims-23-743
10.1148/radiol.2019181659
10.1002/jmri.27954
10.1016/j.prp.2021.153562
10.1007/s00330-017-4912-y
10.1016/j.ejca.2016.09.030
10.2967/jnumed.109.074229
10.3390/clinpract13060123
10.1159/000477443
10.1159/000071199
10.1007/s00256-024-04598-3
10.2214/AJR.14.12462
10.1016/j.ejrad.2016.05.003
10.1001/jamaoncol.2018.4490
10.1097/PAS.0000000000000867
ContentType Journal Article
Copyright 2024 International Society for Magnetic Resonance in Medicine.
2025 International Society for Magnetic Resonance in Medicine
Copyright_xml – notice: 2024 International Society for Magnetic Resonance in Medicine.
– notice: 2025 International Society for Magnetic Resonance in Medicine
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
DOI 10.1002/jmri.29545
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Biotechnology Research Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1522-2586
EndPage 1491
ExternalDocumentID 39037329
10_1002_jmri_29545
JMRI29545
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: Medical Science and Technology Tackling Programme of Henan Province (Joint Co‐construction) Project
  funderid: LHGJ20190662
– fundername: Medical Science and Technology Tackling Programme of Henan Province (Joint Co-construction) Project
  grantid: LHGJ20190662
GroupedDBID ---
-DZ
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1L6
1OB
1OC
1ZS
24P
31~
33P
3O-
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHMBA
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBD
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
H.X
HBH
HDBZQ
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KBYEO
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M65
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RGB
RIWAO
RJQFR
ROL
RWI
RX1
RYL
SAMSI
SUPJJ
SV3
TEORI
TWZ
UB1
V2E
V8K
V9Y
W8V
W99
WBKPD
WHWMO
WIB
WIH
WIJ
WIK
WIN
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
XV2
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGXDD
AGYGG
AIDQK
AIDYY
CITATION
AGQPQ
CGR
CUY
CVF
ECM
EIF
NPM
7QO
7TK
8FD
FR3
K9.
P64
7X8
ID FETCH-LOGICAL-c3165-7f680ebe96a461bfd730b421433b0d4863d4e7c400562e565da1cb119fa9c7543
IEDL.DBID DR2
ISSN 1053-1807
1522-2586
IngestDate Fri Sep 05 12:42:45 EDT 2025
Tue Oct 07 06:08:32 EDT 2025
Thu Apr 24 02:13:28 EDT 2025
Wed Oct 01 04:37:28 EDT 2025
Fri Feb 07 09:41:49 EST 2025
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords magnetic resonance imaging
histological grading
Alveolar Soft Part Sarcoma
prognosis
Language English
License 2024 International Society for Magnetic Resonance in Medicine.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3165-7f680ebe96a461bfd730b421433b0d4863d4e7c400562e565da1cb119fa9c7543
Notes Junhui Yuan, Deshun Xie, and Shaobo Fang contributed consistently to this article.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-4064-5447
0000-0003-0645-5463
0000-0001-6124-7312
PMID 39037329
PQID 3164233105
PQPubID 1006400
PageCount 10
ParticipantIDs proquest_miscellaneous_3083219803
proquest_journals_3164233105
pubmed_primary_39037329
crossref_primary_10_1002_jmri_29545
wiley_primary_10_1002_jmri_29545_JMRI29545
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2025
PublicationDateYYYYMMDD 2025-03-01
PublicationDate_xml – month: 03
  year: 2025
  text: March 2025
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: United States
– name: Nashville
PublicationSubtitle JMRI
PublicationTitle Journal of magnetic resonance imaging
PublicationTitleAlternate J Magn Reson Imaging
PublicationYear 2025
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2017; 40
2017; 41
2023; 13
2019; 291
2019; 5
2019; 50
2021; 225
2017; 27
2006; 130
2023; 389
2024; 53
2014; 272
2020; 11
2017; 9
2016; 56
2018; 47
2017; 70
2021; 17
2016; 113
2016; 85
2019; 29
2017; 18
2022; 55
2018; 99
2003; 65
2010; 51
2014; 203
e_1_2_6_10_1
Lv C (e_1_2_6_29_1) 2023; 13
e_1_2_6_19_1
Spinnato P (e_1_2_6_14_1) 2020; 11
e_1_2_6_13_1
e_1_2_6_11_1
e_1_2_6_12_1
e_1_2_6_17_1
e_1_2_6_18_1
e_1_2_6_15_1
e_1_2_6_16_1
e_1_2_6_21_1
e_1_2_6_20_1
e_1_2_6_9_1
e_1_2_6_8_1
e_1_2_6_5_1
e_1_2_6_4_1
e_1_2_6_7_1
e_1_2_6_6_1
e_1_2_6_25_1
e_1_2_6_24_1
e_1_2_6_3_1
e_1_2_6_23_1
e_1_2_6_2_1
e_1_2_6_22_1
e_1_2_6_28_1
e_1_2_6_27_1
e_1_2_6_26_1
References_xml – volume: 9
  start-page: 415
  year: 2017
  end-page: 429
  article-title: Neoadjuvant chemotherapy in soft tissue sarcomas: Latest evidence and clinical implications
  publication-title: Ther Adv Med Oncol
– volume: 99
  start-page: 473
  year: 2018
  end-page: 481
  article-title: Perfusion MR imaging at 3‐tesla: Can it predict tumor grade and histologic necrosis rate of musculoskeletal sarcoma?
  publication-title: Diagn Interv Imaging
– volume: 29
  start-page: 4485
  year: 2019
  end-page: 4494
  article-title: Conventional MR and diffusion‐weighted imaging of musculoskeletal soft tissue malignancy: Correlation with histologic grading
  publication-title: Eur Radiol
– volume: 53
  start-page: 1343
  year: 2024
  end-page: 1357
  article-title: Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) in differentiation of soft tissue sarcoma from benign lesions: A systematic review of literature
  publication-title: Skeletal Radiol
– volume: 56
  start-page: 147
  year: 2016
  end-page: 154
  article-title: Federation nationale des centers de lutte contre le cancer grading of soft tissue sarcomas on needle core biopsies using surrogate markers
  publication-title: Hum Pathol
– volume: 18
  start-page: 812
  year: 2017
  end-page: 822
  article-title: Histotype‐tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high‐risk soft‐tissue sarcomas (ISG‐STS 1001): An international, open‐label, randomised, controlled, phase 3, multicentre trial
  publication-title: Lancet Oncol
– volume: 41
  start-page: 923
  year: 2017
  end-page: 931
  article-title: The adequacy of core biopsy in the assessment of smooth muscle neoplasms of soft tissues: Implications for treatment and prognosis
  publication-title: Am J Surg Pathol
– volume: 389
  start-page: 911
  year: 2023
  end-page: 921
  article-title: Atezolizumab for advanced alveolar soft part sarcoma
  publication-title: N Engl J Med
– volume: 130
  start-page: 1448
  year: 2006
  end-page: 1453
  article-title: Grading of soft tissue sarcomas: Review and update
  publication-title: Arch Pathol Lab Med
– volume: 11
  start-page: 1524
  year: 2020
  end-page: 1529
  article-title: MRI features as prognostic factors in myxofibrosarcoma: Proposal of MRI grading system
  publication-title: Acad Radiol
– volume: 5
  start-page: 254
  year: 2019
  end-page: 260
  article-title: Diagnosis, prognosis, and treatment of alveolar soft‐part sarcoma: A review
  publication-title: JAMA Oncol
– volume: 27
  start-page: 5024
  year: 2017
  end-page: 5033
  article-title: Multiparametric voxel‐based analyses of standardized uptake values and apparent diffusion coefficients of soft‐tissue tumours with a positron emission tomography/magnetic resonance system: Preliminary results
  publication-title: Eur Radiol
– volume: 70
  start-page: 1
  year: 2017
  end-page: 11
  article-title: (Neo)adjuvant treatment in localised soft tissue sarcoma: The unsolved affair
  publication-title: Eur J Cancer
– volume: 85
  start-page: 1336
  year: 2016
  end-page: 1344
  article-title: Current utilities of imaging in grading musculoskeletal soft tissue sarcomas
  publication-title: Eur J Radiol
– volume: 55
  start-page: 1357
  year: 2022
  end-page: 1375
  article-title: An update in imaging evaluation of histopathological grade of soft tissue sarcomas using structural and quantitative imaging and radiomics
  publication-title: J Magn Reson Imaging
– volume: 17
  start-page: 217
  year: 2021
  end-page: 224
  article-title: Myxofibrosarcoma: Clinical and prognostic value of MRI features
  publication-title: Curr Med Imaging
– volume: 50
  start-page: 11
  year: 2019
  end-page: 27
  article-title: Magnetic resonance imaging biomarkers in musculoskeletal soft tissue tumors: Review of conventional features and focus on nonmorphologic imaging
  publication-title: J Magn Reson Imaging
– volume: 13
  start-page: 1369
  year: 2023
  end-page: 1382
  article-title: Imaging features of alveolar soft part sarcoma: Single institution experience and literature review
  publication-title: Clin Pract
– volume: 272
  start-page: 192
  year: 2014
  end-page: 201
  article-title: Can MR imaging be used to predict tumor grade in soft‐tissue sarcoma?
  publication-title: Radiology
– volume: 225
  year: 2021
  article-title: Ki‐67 immunoexpression and radiological assessment of necrosis improves accuracy of conventional and modified core biopsy systems in predicting the final grade assigned to adult‐soft tissue sarcomas. An international collaborative study
  publication-title: Pathol Res Pract
– volume: 47
  start-page: 829
  year: 2018
  end-page: 840
  article-title: Radiomic analysis of soft tissues sarcomas can distinguish intermediate from high‐grade lesions
  publication-title: J Magn Reson Imaging
– volume: 51
  start-page: 1174
  year: 2010
  end-page: 1181
  article-title: Correlation between glycolytic phenotype and tumor grade in soft‐tissue sarcomas by 18F‐FDG PET
  publication-title: J Nucl Med
– volume: 291
  start-page: 710
  year: 2019
  end-page: 721
  article-title: Soft‐tissue sarcomas: Assessment of MRI features correlating with histologic grade and patient outcome
  publication-title: Radiology
– volume: 65
  start-page: 7
  year: 2003
  end-page: 13
  article-title: Alveolar soft part sarcoma in Japan: Multi‐institutional study of 57 patients from the Japanese musculoskeletal oncology group
  publication-title: Oncology
– volume: 40
  start-page: 580
  year: 2017
  end-page: 585
  article-title: Magnetic resonance features and characteristic vascular pattern of alveolar soft‐part sarcoma
  publication-title: Oncol Res Treat
– volume: 203
  start-page: 1345
  year: 2014
  end-page: 1352
  article-title: Imaging features of alveolar soft‐part sarcoma: A report from Children's Oncology Group Study ARST0332
  publication-title: AJR Am J Roentgenol
– volume: 113
  start-page: 581
  year: 2016
  end-page: 586
  article-title: Prognostic factors in alveolar soft part sarcoma: A SEER analysis
  publication-title: J Surg Oncol
– volume: 13
  start-page: 7269
  year: 2023
  end-page: 7280
  article-title: The dynamic contrast enhanced‐magnetic resonance imaging and diffusion‐weighted imaging features of alveolar soft part sarcoma
  publication-title: Quant Imaging Med Surg
– ident: e_1_2_6_9_1
  doi: 10.1177/1758834017705588
– ident: e_1_2_6_24_1
  doi: 10.1016/j.diii.2018.02.005
– ident: e_1_2_6_5_1
  doi: 10.1002/jso.24183
– ident: e_1_2_6_18_1
  doi: 10.1148/radiol.14131871
– ident: e_1_2_6_27_1
  doi: 10.2174/1573405616999200729152135
– ident: e_1_2_6_11_1
  doi: 10.5858/2006-130-1448-GOSTSR
– ident: e_1_2_6_25_1
  doi: 10.1007/s00330-018-5845-9
– ident: e_1_2_6_7_1
  doi: 10.1016/j.humpath.2016.06.008
– ident: e_1_2_6_8_1
  doi: 10.1016/S1470-2045(17)30334-0
– ident: e_1_2_6_17_1
  doi: 10.1002/jmri.25791
– ident: e_1_2_6_3_1
  doi: 10.1056/NEJMoa2303383
– ident: e_1_2_6_13_1
  doi: 10.1002/jmri.26659
– volume: 13
  start-page: 7269
  year: 2023
  ident: e_1_2_6_29_1
  article-title: The dynamic contrast enhanced‐magnetic resonance imaging and diffusion‐weighted imaging features of alveolar soft part sarcoma
  publication-title: Quant Imaging Med Surg
  doi: 10.21037/qims-23-743
– ident: e_1_2_6_20_1
  doi: 10.1148/radiol.2019181659
– ident: e_1_2_6_6_1
  doi: 10.1002/jmri.27954
– ident: e_1_2_6_23_1
  doi: 10.1016/j.prp.2021.153562
– ident: e_1_2_6_19_1
  doi: 10.1007/s00330-017-4912-y
– ident: e_1_2_6_10_1
  doi: 10.1016/j.ejca.2016.09.030
– ident: e_1_2_6_16_1
  doi: 10.2967/jnumed.109.074229
– ident: e_1_2_6_26_1
  doi: 10.3390/clinpract13060123
– ident: e_1_2_6_28_1
  doi: 10.1159/000477443
– ident: e_1_2_6_4_1
  doi: 10.1159/000071199
– ident: e_1_2_6_21_1
  doi: 10.1007/s00256-024-04598-3
– volume: 11
  start-page: 1524
  year: 2020
  ident: e_1_2_6_14_1
  article-title: MRI features as prognostic factors in myxofibrosarcoma: Proposal of MRI grading system
  publication-title: Acad Radiol
– ident: e_1_2_6_22_1
  doi: 10.2214/AJR.14.12462
– ident: e_1_2_6_15_1
  doi: 10.1016/j.ejrad.2016.05.003
– ident: e_1_2_6_2_1
  doi: 10.1001/jamaoncol.2018.4490
– ident: e_1_2_6_12_1
  doi: 10.1097/PAS.0000000000000867
SSID ssj0009945
Score 2.4652805
Snippet Background Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor...
Alveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor variability can...
BackgroundAlveolar Soft Part Sarcoma (ASPS) is a rare, aggressive cancer whose diagnosis and treatment depend on histological grading. However, tumor...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 1482
SubjectTerms Adolescent
Adult
Aged
Alveolar Soft Part Sarcoma
Bone tumors
Child
Edema
Evaluation
Female
Field strength
Hazard assessment
Hazard identification
Heterogeneity
histological grading
Humans
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Medical prognosis
Metastases
Middle Aged
Necrosis
Neoplasm Grading
Prognosis
Regression models
Retrospective Studies
Sarcoma
Sarcoma, Alveolar Soft Part - diagnostic imaging
Sarcoma, Alveolar Soft Part - pathology
Soft tissue sarcoma
Soft tissues
Statistical analysis
Statistical models
Statistical tests
Survival
Survival Analysis
Tumors
Young Adult
Title Alveolar Soft Tissue Sarcoma: Correlation of MRI Features With Histological Grading and Patient Prognosis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmri.29545
https://www.ncbi.nlm.nih.gov/pubmed/39037329
https://www.proquest.com/docview/3164233105
https://www.proquest.com/docview/3083219803
Volume 61
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1053-1807
  databaseCode: DR2
  dateStart: 19990101
  customDbUrl:
  isFulltext: true
  eissn: 1522-2586
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0009945
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEB5CHkJe2lxtNxcK6VPAG-tYWQp5CSEnbAk5aF6KkWyZbA477JGH_PqMZO8uaSGQvhkkI3lGM_rGGn0D8FMkygmV06ijaR55yu7IFkpGiCWYNJYlhfS3kbu_5OmNOL_t3M7A_vguTM0PMfnh5i0j-Gtv4MYOdqekofdP_V7bn1L5G-aUyxBPXU65o7QOFYoRP_CIqjiZcJOy3emr73ejfyDme8Qatpzjr_BnPNk60-ShPRradvb6F4_j_37NAnxpsCg5qBfPIsy4cgnmus1p-zL0Dh5fnA99yRU6a3IddESu0DSqJ7NHDn1hjzqVjlQF6V6eEQ8oRxjAk9-94R0JFCSNbyUn_ZCtT0yZk4uazJVc9Cuf59cbrMDN8dH14WnUlGaIMk5lJ0IVqhj1r6URktoiR0dhBUPwxW2cCyV5LlySCc80yhyCxtzQzFKqC6OzpCP4N5gtq9L9AKKMyGOpWSGxv0kwwHGFJyUUUlEjTdyC7bGK0ueagSOtuZZZ6qWWBqm1YH2svbSxwkGKU0W0iAAWm7cmzWg__lDElK4aYZ_Y12rSKuYt-F5rfTIM1zFPONMt2Am6-2D89BylHJ5WP9N5DeaZLygcktrWYXbYH7kNRDlDuxlW8xuzqPYz
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VVgIu0AItCwWM4ISUbfyIY3OrKsr2sVXVbkVvkZM46gJN0D448OuZcdJdlUpIcItkR05mPONv7PE3AO9VarwyJY8Sy8uIKLujvDI6QiwhtMtFWmm6jTw80YMLdXiZXHa5OXQXpuWHWGy4kWUEf00GThvSO0vW0K_Xk3GfjqmSe7CmNAYqhInOluxR1oYaxYggZMRNnC7YScXO8t3b69EdkHkbs4ZFZ_9xW1l1GrgKKdfkW38-y_vFrz-YHP_7f9bhUQdH2W47fzZgxddP4P6wO3B_CuPd7z89Rb_sHP01GwU1sXO0jubafWR7VNujzaZjTcWGZweMMOUcY3j2ZTy7YoGFpHOv7PMkJOwzV5fstOVzZaeThlL9xtNncLH_abQ3iLrqDFEhuU4i1KKJcQpY7ZTmeVWir8iVQPwl87hURstS-bRQRDYqPOLG0vEi59xWzhZpouQmrNZN7Z8DM06Vsbai0tjfpRjj-Ip4CZU23GkX9-DdjY6yHy0JR9bSLYuMpJYFqfVg-0Z9WWeI0ww_FQEjYlhsfrtoRhOicxFX-2aOfWIq12RNLHuw1ap9MYy0sUylsD34EJT3l_GzQ5RyeHrxL53fwIPBaHicHR-cHL2Eh4LqC4cct21YnU3m_hWCnln-Okzt3yd7-lQ
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1JT9wwFLZaKqFegG4wQFtX7alShniJY3ND0GFpB41YVG6REztiWBI0C4f--r7nhBlRpErtLZIdOfHze_5sf_4eIV9kqr3UjkWJYS5Cye4oL7WKAEtwZXOelgpvI_eP1cG5PLpILlpuDt6FafQhZhtu6BkhXqOD-ztXbs1VQ69uR8MuHlMlz8kLmRiNjL69k7l6lDEhRzEgCBExHaczdVK-NX_38Xz0BGQ-xqxh0uktN5lVx0GrELkm193pJO8Wv_5Qcvzv_1khSy0cpTvN-HlFnvnqNVnstwfub8hw5-be4-qXnkK8pmfBTPQUvKO-tdt0F3N7NGw6Wpe0f3JIEVNOYQ1Pfw4nlzSokLThle6PAmGf2srRQaPnSgejGql-w_Fbct77drZ7ELXZGaJCMJVEYEUdwxAwykrF8tJBrMglB_wl8thJrYSTPi0kio1yD7jRWVbkjJnSmiJNpHhHFqq68muEaitdrAwvFdS3KaxxfIm6hFJpZpWNO-Tzg42yu0aEI2vklnmGvZaFXuuQzQfzZa0jjjP4VACMgGGh-NOsGFwIz0Vs5esp1IkxXZPRseiQ1cbss2aEiUUquOmQr8F4f2k_O4JeDk_r_1L5I1kc7PWyH4fH3zfIS47phQPFbZMsTEZT_x4wzyT_EEb2b9b0-dg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Alveolar+Soft+Tissue+Sarcoma%3A+Correlation+of+MRI+Features+With+Histological+Grading+and+Patient+Prognosis&rft.jtitle=Journal+of+magnetic+resonance+imaging&rft.au=Yuan%2C+Junhui&rft.au=Xie%2C+Deshun&rft.au=Fang%2C+Shaobo&rft.au=Fan%2C+Meng&rft.date=2025-03-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1053-1807&rft.eissn=1522-2586&rft.volume=61&rft.issue=3&rft.spage=1482&rft.epage=1491&rft_id=info:doi/10.1002%2Fjmri.29545&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1053-1807&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1053-1807&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1053-1807&client=summon